Skip to content

Drug interactions

Ofatumumab sc + Siponimod

Severity: Major

Ofatumumab sc and Siponimod: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Subcutaneous ofatumumab depletes B cells, and siponimod lowers circulating lymphocytes, so combined use may add to infection risk. B-cell effects of ofatumumab persist after discontinuation.

What this interaction means in plain words

Ofatumumab sc and Siponimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Additive immunosuppression from anti-CD20 B-cell depletion and S1P receptor-mediated lymphocyte sequestration.

What to do

Avoid using the two together; when switching, consider the duration of immune effects of the prior drug and monitor lymphocyte counts and infection signs.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ofatumumab sc and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ofatumumab sc with Siponimod?

MediHelp rates the interaction as major. Ofatumumab sc and Siponimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Subcutaneous ofatumumab depletes B cells, and siponimod lowers circulating lymphocytes, so combined use may add to infection risk. B-cell effects of ofatumumab persist after discontinuation.

How serious is the interaction between Ofatumumab sc and Siponimod?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid using the two together; when switching, consider the duration of immune effects of the prior drug and monitor lymphocyte counts and infection signs.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in